Gum disease and immune changes in Alzheimer's brains
IMPORTANCE OF PERIODONTITIS IN THE INNATE IMMUNE REGULATION OF ALZHEIMER'S DISEASE
This project looks at whether oral infections from gum disease make Alzheimer's worse by changing brain immune cells and inflammation in older adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11299499 on NIH RePORTER |
What this research studies
From a patient point of view, researchers are testing how a common gum bug, Porphyromonas gingivalis, might travel to the brain and worsen Alzheimer-related changes. They will use oral infection experiments in Alzheimer's-model mice to measure amyloid buildup, brain inflammation, microglial activation, and synapse loss. The team will focus on the complement protein C1q to see if it helps drive harmful microglial responses after gum infection. Results aim to clarify whether periodontitis can raise Alzheimer's risk or speed disease and to guide future patient-focused prevention or treatment efforts.
Who could benefit from this research
Good fit: Ideal candidates for future related trials would be older adults with periodontitis or people at increased Alzheimer's risk (for example, with mild cognitive changes or family history).
Not a fit: People without gum disease, much younger adults, or patients whose Alzheimer's is driven by unrelated mechanisms may not see direct benefit from these findings.
Why it matters
Potential benefit: If true, this work could point to gum disease and related immune signals as preventable or treatable contributors to Alzheimer's, suggesting new prevention or therapy strategies.
How similar studies have performed: Epidemiologic data and prior animal studies have linked Porphyromonas gingivalis and periodontal inflammation to worsened Alzheimer's pathology, but translating this into human treatments is still novel.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Zhang, Ping — University of Alabama at Birmingham
- Study coordinator: Zhang, Ping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.